DBV Technologies (DBVT) News Today $3.21 -0.01 (-0.31%) (As of 05:56 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.comDecember 16 at 2:08 AM | americanbankingnews.comStockNews.com Initiates Coverage on DBV Technologies (NASDAQ:DBVT)StockNews.com initiated coverage on shares of DBV Technologies in a report on Monday. They issued a "hold" rating for the company.December 16 at 2:06 AM | marketbeat.comDBV Technologies Aligns with FDA for Viaskin Peanut ApprovalDecember 13, 2024 | markets.businessinsider.comDBV jumps 52% to $4.99 after aligning with FDA on approval pathwayDecember 12, 2024 | markets.businessinsider.comDBV Technologies announces FDA alignment on Viaskin Peanut patch program pathwayDecember 12, 2024 | markets.businessinsider.comStocks to Watch: Adobe, Champions Oncology, DBV TechnologiesDecember 11, 2024 | marketwatch.comDBV Shares Rise 31%, Confirms Alignment With FDA on Accelerated Approval for Peanut PatchDecember 11, 2024 | marketwatch.comDBV stock rallies post-market on FDA Viaskin updateDecember 11, 2024 | seekingalpha.comDBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-OldDecember 11, 2024 | globenewswire.comDBV Technologies (NASDAQ:DBVT) Given Market Outperform Rating at JMP SecuritiesDecember 11, 2024 | americanbankingnews.comDBV Technologies price target raised to $10 from $5 at JMP SecuritiesDecember 6, 2024 | markets.businessinsider.comDBV Technologies S.A. (NASDAQ:DBVT) Short Interest Down 5.3% in NovemberDBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) was the recipient of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 1,260,000 shares, a decline of 5.3% from the October 31st total of 1,330,000 shares. Based on an average trading volume of 671,600 shares, the short-interest ratio is currently 1.9 days. Approximately 1.3% of the shares of the company are sold short.December 3, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.comStockNews.com started coverage on shares of DBV Technologies in a research report on Saturday. They set a "hold" rating on the stock.November 30, 2024 | marketbeat.comEleven option delistings on November 18thNovember 18, 2024 | markets.businessinsider.comDBV Technologies (NASDAQ:DBVT) Coverage Initiated at StockNews.comStockNews.com assumed coverage on shares of DBV Technologies in a report on Thursday. They set a "hold" rating for the company.November 14, 2024 | marketbeat.comDBV Technologies announces ADS ratio changeNovember 13, 2024 | markets.businessinsider.comDBV Technologies Stock to Reverse Split on Friday, November 29th (NASDAQ:DBVT)DBV Technologies S.A. (NASDAQ:DBVT - Free Report)'s stock is set to reverse split on the morning of Friday, November 29th. The 1-5 reverse split was announced on Monday, November 11th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, November 28th.November 13, 2024 | marketbeat.comDBV Technologies Announces Plan to Implement ADS Ratio ChangeNovember 11, 2024 | globenewswire.comDBV Technologies Reports Third Quarter 2024 Financial ResultsNovember 6, 2024 | globenewswire.comDBV Technologies (NASDAQ:DBVT) Stock Passes Above Fifty Day Moving Average - Here's WhyDBV Technologies (NASDAQ:DBVT) Stock Price Passes Above Fifty Day Moving Average - Here's WhyNovember 6, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.comStockNews.com began coverage on shares of DBV Technologies in a report on Tuesday. They set a "hold" rating for the company.October 29, 2024 | marketbeat.comDBV Technologies rating suspended at Goldman SachsOctober 25, 2024 | markets.businessinsider.comHC Wainwright Has Positive Estimate for DBVT FY2024 EarningsDBV Technologies S.A. (NASDAQ:DBVT - Free Report) - Research analysts at HC Wainwright increased their FY2024 earnings per share estimates for DBV Technologies in a report issued on Wednesday, October 23rd. HC Wainwright analyst A. Fein now anticipates that the company will post earnings per sharOctober 25, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Price Target Increased to $7.00 by Analysts at HC WainwrightHC Wainwright increased their price objective on DBV Technologies from $5.00 to $7.00 and gave the company a "buy" rating in a research report on Thursday.October 24, 2024 | marketbeat.comFrench Biotech Stock Soars On Regulatory UpdatesOctober 24, 2024 | msn.comDBV Technologies price target raised to $7 from $5 at H.C. WainwrightOctober 24, 2024 | markets.businessinsider.comDBV Tech spikes after regulatory update on lead assetOctober 24, 2024 | seekingalpha.comPenny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval PathwayOctober 24, 2024 | msn.comDBV Technologies Rally 47% Following Positive Updates for Peanut Allergy PatchOctober 22, 2024 | marketwatch.comDBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and EuropeOctober 22, 2024 | globenewswire.comDBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.comStockNews.com began coverage on DBV Technologies in a research note on Monday. They set a "hold" rating on the stock.October 21, 2024 | marketbeat.comDBV Technologies to Participate in Upcoming ACAAI 2024 CongressOctober 18, 2024 | globenewswire.comDBV Technologies SA (DBVT) (Q2 2024) Earnings Call Highlights: Strategic Advances Amid ...October 9, 2024 | finance.yahoo.comDBV Technologies (NASDAQ:DBVT) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comPoint72 Asset Management L.P. Has $1.25 Million Stock Holdings in DBV Technologies S.A. (NASDAQ:DBVT)Point72 Asset Management L.P. lessened its position in DBV Technologies S.A. (NASDAQ:DBVT - Free Report) by 50.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,556,250 shares of the company's stock after selling 1,556,250 shares durOctober 4, 2024 | marketbeat.comDBV Technologies Completes Screening for the VITESSE Phase 3 Clinical TrialSeptember 23, 2024 | globenewswire.comShort Interest in DBV Technologies S.A. (NASDAQ:DBVT) Declines By 5.1%DBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) was the target of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 278,800 shares, a decrease of 5.1% from the August 15th total of 293,700 shares. Based on an average daily trading volume, of 50,900 shares, the short-interest ratio is presently 5.5 days. Approximately 0.3% of the company's shares are sold short.September 18, 2024 | marketbeat.comDBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comDBV Technologies (NASDAQ:DBVT) Stock Price Crosses Below 50-Day Moving Average of $0.89DBV Technologies (NASDAQ:DBVT) Stock Price Passes Below 50-Day Moving Average of $0.89September 3, 2024 | marketbeat.comDBV Technologies S.A. (NASDAQ:DBVT) Sees Large Increase in Short InterestDBV Technologies S.A. (NASDAQ:DBVT - Get Free Report) was the target of a significant growth in short interest in July. As of July 31st, there was short interest totalling 307,100 shares, a growth of 6.3% from the July 15th total of 288,800 shares. Currently, 0.3% of the company's stock are short sold. Based on an average trading volume of 94,100 shares, the short-interest ratio is currently 3.3 days.August 18, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Now Covered by StockNews.comStockNews.com started coverage on DBV Technologies in a research report on Saturday. They set a "hold" rating on the stock.August 10, 2024 | marketbeat.comHC Wainwright Reaffirms Buy Rating for DBV Technologies (NASDAQ:DBVT)HC Wainwright restated a "buy" rating and set a $5.00 price target on shares of DBV Technologies in a research report on Thursday.August 1, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Price Target Raised to $5.00JMP Securities increased their price objective on DBV Technologies from $4.00 to $5.00 and gave the company a "market outperform" rating in a research report on Wednesday.July 31, 2024 | marketbeat.comDBV Technologies (NASDAQ:DBVT) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPSDBV Technologies (NASDAQ:DBVT - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.34) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.08). The business had revenue of $1.16 million for the quarter, compared to the consensus estimate of $1.42 million. DBV Technologies had a negative return on equity of 56.76% and a negative net margin of 530.89%. During the same period in the previous year, the company posted ($0.26) earnings per share.July 31, 2024 | marketbeat.comDBV Technologies S.A.: DBV Technologies Announces Filing of 2024 Half-Year Report ? Conditions for Accessing or Consulting the ReportJuly 31, 2024 | finanznachrichten.deDBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the ReportJuly 30, 2024 | globenewswire.comDBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial ResultsJuly 30, 2024 | globenewswire.comDBV Technologies (DBVT) Scheduled to Post Earnings on TuesdayDBV Technologies (NASDAQ:DBVT) will be releasing earnings after the market closes on Tuesday, July 30, Zacks reports.July 29, 2024 | marketbeat.comDBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024July 29, 2024 | globenewswire.comDBV Technologies (NASDAQ:DBVT) Shares Cross Above 50 Day Moving Average of $0.94DBV Technologies (NASDAQ:DBVT) Stock Price Passes Above Fifty Day Moving Average of $0.94July 25, 2024 | marketbeat.com Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Healthcare Takes A Big Step Forward With The Help of A.I. (Ad)To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare. Click here to learn more about the booming eHealth industry - and see which microcap will be at the DBVT Media Mentions By Week DBVT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DBVT News Sentiment▼0.570.79▲Average Medical News Sentiment DBVT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DBVT Articles This Week▼112▲DBVT Articles Average Week Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Atea Pharmaceuticals News Atyr PHARMA News Mersana Therapeutics News Chimerix News Heron Therapeutics News Fulcrum Therapeutics News Aurora Cannabis News Fate Therapeutics News Lexeo Therapeutics News DiaMedica Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DBVT) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DBV Technologies S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share DBV Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DBVT Stock Alerts